STOCK TITAN

[8-K] OSR Holdings, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Callan JMB Inc. (CJMB) has entered into a $25 million Equity Line of Credit (ELOC) with a single investor. Over an 18-month term, the company may, at its sole discretion, issue Regular Purchase notices of $0.5-$2.0 million per draw at 95 % of the lowest daily VWAP during a defined measurement period (80 % if CJMB is delisted from Nasdaq). An additional Exemption Purchase option allows draws up to $1 million on similar pricing, plus the investor receives bonus shares equal to 10 % of each exemption draw.

To secure the facility CJMB will issue 15,000 commitment shares and cap the investor’s ownership at 4.99 %. Failure to file or have declared effective an S-1 covering resale of the ELOC and commitment shares within the agreed deadlines triggers a 25,000-share penalty for each breach. All sales are exempt from registration under Section 4(a)(2) until the registration statement is effective. The agreement provides flexible, on-demand financing but could create dilution because shares are sold at a discount and additional shares may be issued as penalties or bonuses.

Callan JMB Inc. (CJMB) ha stipulato una linea di credito azionaria (ELOC) da 25 milioni di dollari con un singolo investitore. Nel corso di un periodo di 18 mesi, la società potrà, a sua esclusiva discrezione, emettere avvisi di acquisto regolari da 0,5 a 2,0 milioni di dollari per ogni prelievo al 95% del VWAP giornaliero più basso durante un periodo di misurazione definito (all’80% se CJMB viene esclusa dal Nasdaq). Un’opzione aggiuntiva di acquisto esente permette prelievi fino a 1 milione di dollari a prezzi simili, con l’investitore che riceve azioni bonus pari al 10% di ogni prelievo esente.

Per garantire la linea di credito, CJMB emetterà 15.000 azioni di impegno e limiterà la proprietà dell’investitore al 4,99%. Il mancato deposito o l’assenza di efficacia della dichiarazione S-1 relativa alla rivendita dell’ELOC e delle azioni di impegno entro le scadenze concordate comporta una penalità di 25.000 azioni per ogni violazione. Tutte le vendite sono esenti da registrazione ai sensi della Sezione 4(a)(2) fino a quando la dichiarazione di registrazione non è efficace. L’accordo offre un finanziamento flessibile e su richiesta, ma potrebbe comportare diluizione poiché le azioni vengono vendute a sconto e possono essere emesse azioni aggiuntive come penalità o bonus.

Callan JMB Inc. (CJMB) ha celebrado una línea de crédito de capital (ELOC) de 25 millones de dólares con un único inversor. Durante un plazo de 18 meses, la empresa podrá, a su entera discreción, emitir avisos de compra regulares de 0,5 a 2,0 millones de dólares por cada extracción al 95% del VWAP diario más bajo durante un período de medición definido (80 % si CJMB es excluida del Nasdaq). Una opción adicional de compra exenta permite extracciones de hasta 1 millón de dólares con precios similares, y el inversor recibe acciones adicionales equivalentes al 10 % de cada extracción exenta.

Para asegurar la facilidad, CJMB emitirá 15,000 acciones de compromiso y limitará la propiedad del inversor al 4,99%. El incumplimiento en la presentación o la falta de efectividad de un formulario S-1 que cubra la reventa del ELOC y las acciones de compromiso dentro de los plazos acordados desencadena una penalización de 25,000 acciones por cada infracción. Todas las ventas están exentas de registro según la Sección 4(a)(2) hasta que la declaración de registro sea efectiva. El acuerdo proporciona financiamiento flexible y bajo demanda, pero podría generar dilución porque las acciones se venden con descuento y se pueden emitir acciones adicionales como penalizaciones o bonificaciones.

Callan JMB Inc. (CJMB)는 단일 투자자와 함께 2,500만 달러 규모의 주식 신용 한도(ELOC) 계약을 체결했습니다. 18개월 기간 동안 회사는 전적으로 자율적으로 0.5~2.0백만 달러 범위 내에서 정기 매입 통지를 발행할 수 있으며, 이는 지정된 측정 기간 동안 가장 낮은 일일 VWAP의 95% 가격으로 진행됩니다(만약 CJMB가 나스닥에서 상장 폐지되면 80%). 추가 면제 매입 옵션을 통해 유사한 가격으로 최대 100만 달러까지 인출할 수 있으며, 투자자는 각 면제 인출액의 10%에 해당하는 보너스 주식을 받습니다.

이 시설을 확보하기 위해 CJMB는 15,000명의 약정 주식을 발행하고 투자자의 소유 지분을 4.99%로 제한합니다. ELOC 및 약정 주식의 재판매를 위한 S-1 서류를 합의된 기한 내에 제출하지 않거나 효력이 발생하지 않을 경우, 위반 건당 25,000주의 페널티가 부과됩니다. 모든 판매는 등록 명세서가 효력을 발휘할 때까지 섹션 4(a)(2)에 따라 등록 면제됩니다. 이 계약은 유연하고 필요에 따라 자금을 조달할 수 있게 하지만, 주식이 할인된 가격에 판매되고 페널티나 보너스로 추가 주식이 발행될 수 있어 희석 효과가 발생할 수 있습니다.

Callan JMB Inc. (CJMB) a conclu une ligne de crédit en actions (ELOC) de 25 millions de dollars avec un seul investisseur. Sur une durée de 18 mois, la société peut, à sa seule discrétion, émettre des avis d'achat réguliers de 0,5 à 2,0 millions de dollars par tirage à 95 % du VWAP journalier le plus bas durant une période de mesure définie (80 % si CJMB est retirée du Nasdaq). Une option d'achat supplémentaire exonérée permet des tirages jusqu'à 1 million de dollars à des prix similaires, et l'investisseur reçoit des actions bonus équivalentes à 10 % de chaque tirage exonéré.

Pour garantir la facilité, CJMB émettra 15 000 actions d'engagement et plafonnera la participation de l'investisseur à 4,99 %. Le non-dépôt ou l'absence d'effet d'un formulaire S-1 couvrant la revente de l'ELOC et des actions d'engagement dans les délais convenus entraîne une pénalité de 25 000 actions par infraction. Toutes les ventes sont exemptées d'enregistrement en vertu de la Section 4(a)(2) jusqu'à ce que la déclaration d'enregistrement soit effective. L'accord offre un financement flexible à la demande, mais pourrait entraîner une dilution car les actions sont vendues à prix réduit et des actions supplémentaires peuvent être émises en pénalités ou bonus.

Callan JMB Inc. (CJMB) hat eine 25-Millionen-Dollar-Aktienkreditlinie (ELOC) mit einem einzelnen Investor abgeschlossen. Über eine Laufzeit von 18 Monaten kann das Unternehmen nach eigenem Ermessen regelmäßige Kaufmitteilungen über 0,5 bis 2,0 Millionen Dollar pro Abruf zum 95 % des niedrigsten täglichen VWAP während eines definierten Messzeitraums ausgeben (80 %, falls CJMB vom Nasdaq delistet wird). Eine zusätzliche Ausnahme-Kaufoption erlaubt Abrufe bis zu 1 Million Dollar zu ähnlichen Konditionen, zudem erhält der Investor Bonusaktien in Höhe von 10 % jedes Ausnahmeabrufs.

Zur Sicherung der Einrichtung wird CJMB 15.000 Verpflichtungsaktien ausgeben und den Anteil des Investors auf 4,99 % begrenzen. Das Versäumnis, eine S-1-Erklärung für den Wiederverkauf der ELOC- und Verpflichtungsaktien innerhalb der vereinbarten Fristen einzureichen oder wirksam werden zu lassen, führt zu einer Strafe von 25.000 Aktien pro Verstoß. Alle Verkäufe sind gemäß Abschnitt 4(a)(2) von der Registrierung befreit, bis die Registrierungserklärung wirksam ist. Die Vereinbarung bietet flexible, bedarfsgesteuerte Finanzierung, kann jedoch zu Verwässerung führen, da Aktien mit Abschlag verkauft werden und zusätzliche Aktien als Strafen oder Boni ausgegeben werden können.

Positive
  • Access to up to $25 million in flexible, on-demand equity financing, improving liquidity without increasing debt.
  • 4.99 % ownership cap limits control risk from the financing counterparty.
  • No obligation to draw; management can time capital raises based on market conditions.
Negative
  • Shares sold at 5-20 % discount to VWAP, creating immediate dilution and potential downward price pressure.
  • Commitment, bonus and penalty shares increase share count even without cash proceeds.
  • Registration statement deadlines carry 25 k-share penalties, adding execution risk.

Insights

TL;DR: Optional $25 m ELOC boosts liquidity but adds discounted share supply and dilution risk.

The facility gives CJMB rapid access to capital without upfront debt service, helpful for working-capital or growth needs. Pricing at 95 % of VWAP is in line with small-cap PIPE norms, yet still dilutive and potentially pressures the share price, especially if draw frequency is high. The 4.99 % cap prevents a change of control, but commitment, bonus and penalty shares embed additional dilution. Timely filing of the resale S-1 is critical to avoid issuing 25 k penalty shares. Overall, the agreement is neutral-to-slightly positive for liquidity, negative for existing shareholders’ ownership percentage.

TL;DR: Governance safeguards exist, but discounted share issuance raises dilution and market-impact concerns.

The Purchase and Registration Rights agreements use standard reps & warranties and a sub-5 % ownership cap, limiting concentration risk. However, discount mechanics (up to 20 % if Nasdaq listing is lost) and mandatory bonus shares for exemption purchases incentivize repeated draws that may depress trading prices. Penalty-share clauses for late registration create additional downside. Investors should monitor management’s capital planning discipline and registration timeline adherence. Impact classified as neutral; beneficial to solvency but with notable shareholder dilution risk.

Callan JMB Inc. (CJMB) ha stipulato una linea di credito azionaria (ELOC) da 25 milioni di dollari con un singolo investitore. Nel corso di un periodo di 18 mesi, la società potrà, a sua esclusiva discrezione, emettere avvisi di acquisto regolari da 0,5 a 2,0 milioni di dollari per ogni prelievo al 95% del VWAP giornaliero più basso durante un periodo di misurazione definito (all’80% se CJMB viene esclusa dal Nasdaq). Un’opzione aggiuntiva di acquisto esente permette prelievi fino a 1 milione di dollari a prezzi simili, con l’investitore che riceve azioni bonus pari al 10% di ogni prelievo esente.

Per garantire la linea di credito, CJMB emetterà 15.000 azioni di impegno e limiterà la proprietà dell’investitore al 4,99%. Il mancato deposito o l’assenza di efficacia della dichiarazione S-1 relativa alla rivendita dell’ELOC e delle azioni di impegno entro le scadenze concordate comporta una penalità di 25.000 azioni per ogni violazione. Tutte le vendite sono esenti da registrazione ai sensi della Sezione 4(a)(2) fino a quando la dichiarazione di registrazione non è efficace. L’accordo offre un finanziamento flessibile e su richiesta, ma potrebbe comportare diluizione poiché le azioni vengono vendute a sconto e possono essere emesse azioni aggiuntive come penalità o bonus.

Callan JMB Inc. (CJMB) ha celebrado una línea de crédito de capital (ELOC) de 25 millones de dólares con un único inversor. Durante un plazo de 18 meses, la empresa podrá, a su entera discreción, emitir avisos de compra regulares de 0,5 a 2,0 millones de dólares por cada extracción al 95% del VWAP diario más bajo durante un período de medición definido (80 % si CJMB es excluida del Nasdaq). Una opción adicional de compra exenta permite extracciones de hasta 1 millón de dólares con precios similares, y el inversor recibe acciones adicionales equivalentes al 10 % de cada extracción exenta.

Para asegurar la facilidad, CJMB emitirá 15,000 acciones de compromiso y limitará la propiedad del inversor al 4,99%. El incumplimiento en la presentación o la falta de efectividad de un formulario S-1 que cubra la reventa del ELOC y las acciones de compromiso dentro de los plazos acordados desencadena una penalización de 25,000 acciones por cada infracción. Todas las ventas están exentas de registro según la Sección 4(a)(2) hasta que la declaración de registro sea efectiva. El acuerdo proporciona financiamiento flexible y bajo demanda, pero podría generar dilución porque las acciones se venden con descuento y se pueden emitir acciones adicionales como penalizaciones o bonificaciones.

Callan JMB Inc. (CJMB)는 단일 투자자와 함께 2,500만 달러 규모의 주식 신용 한도(ELOC) 계약을 체결했습니다. 18개월 기간 동안 회사는 전적으로 자율적으로 0.5~2.0백만 달러 범위 내에서 정기 매입 통지를 발행할 수 있으며, 이는 지정된 측정 기간 동안 가장 낮은 일일 VWAP의 95% 가격으로 진행됩니다(만약 CJMB가 나스닥에서 상장 폐지되면 80%). 추가 면제 매입 옵션을 통해 유사한 가격으로 최대 100만 달러까지 인출할 수 있으며, 투자자는 각 면제 인출액의 10%에 해당하는 보너스 주식을 받습니다.

이 시설을 확보하기 위해 CJMB는 15,000명의 약정 주식을 발행하고 투자자의 소유 지분을 4.99%로 제한합니다. ELOC 및 약정 주식의 재판매를 위한 S-1 서류를 합의된 기한 내에 제출하지 않거나 효력이 발생하지 않을 경우, 위반 건당 25,000주의 페널티가 부과됩니다. 모든 판매는 등록 명세서가 효력을 발휘할 때까지 섹션 4(a)(2)에 따라 등록 면제됩니다. 이 계약은 유연하고 필요에 따라 자금을 조달할 수 있게 하지만, 주식이 할인된 가격에 판매되고 페널티나 보너스로 추가 주식이 발행될 수 있어 희석 효과가 발생할 수 있습니다.

Callan JMB Inc. (CJMB) a conclu une ligne de crédit en actions (ELOC) de 25 millions de dollars avec un seul investisseur. Sur une durée de 18 mois, la société peut, à sa seule discrétion, émettre des avis d'achat réguliers de 0,5 à 2,0 millions de dollars par tirage à 95 % du VWAP journalier le plus bas durant une période de mesure définie (80 % si CJMB est retirée du Nasdaq). Une option d'achat supplémentaire exonérée permet des tirages jusqu'à 1 million de dollars à des prix similaires, et l'investisseur reçoit des actions bonus équivalentes à 10 % de chaque tirage exonéré.

Pour garantir la facilité, CJMB émettra 15 000 actions d'engagement et plafonnera la participation de l'investisseur à 4,99 %. Le non-dépôt ou l'absence d'effet d'un formulaire S-1 couvrant la revente de l'ELOC et des actions d'engagement dans les délais convenus entraîne une pénalité de 25 000 actions par infraction. Toutes les ventes sont exemptées d'enregistrement en vertu de la Section 4(a)(2) jusqu'à ce que la déclaration d'enregistrement soit effective. L'accord offre un financement flexible à la demande, mais pourrait entraîner une dilution car les actions sont vendues à prix réduit et des actions supplémentaires peuvent être émises en pénalités ou bonus.

Callan JMB Inc. (CJMB) hat eine 25-Millionen-Dollar-Aktienkreditlinie (ELOC) mit einem einzelnen Investor abgeschlossen. Über eine Laufzeit von 18 Monaten kann das Unternehmen nach eigenem Ermessen regelmäßige Kaufmitteilungen über 0,5 bis 2,0 Millionen Dollar pro Abruf zum 95 % des niedrigsten täglichen VWAP während eines definierten Messzeitraums ausgeben (80 %, falls CJMB vom Nasdaq delistet wird). Eine zusätzliche Ausnahme-Kaufoption erlaubt Abrufe bis zu 1 Million Dollar zu ähnlichen Konditionen, zudem erhält der Investor Bonusaktien in Höhe von 10 % jedes Ausnahmeabrufs.

Zur Sicherung der Einrichtung wird CJMB 15.000 Verpflichtungsaktien ausgeben und den Anteil des Investors auf 4,99 % begrenzen. Das Versäumnis, eine S-1-Erklärung für den Wiederverkauf der ELOC- und Verpflichtungsaktien innerhalb der vereinbarten Fristen einzureichen oder wirksam werden zu lassen, führt zu einer Strafe von 25.000 Aktien pro Verstoß. Alle Verkäufe sind gemäß Abschnitt 4(a)(2) von der Registrierung befreit, bis die Registrierungserklärung wirksam ist. Die Vereinbarung bietet flexible, bedarfsgesteuerte Finanzierung, kann jedoch zu Verwässerung führen, da Aktien mit Abschlag verkauft werden und zusätzliche Aktien als Strafen oder Boni ausgegeben werden können.

false 0001840425 0001840425 2025-07-24 2025-07-24 0001840425 OSRH:CommonStockParValue0.0001PerShareMember 2025-07-24 2025-07-24 0001840425 OSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember 2025-07-24 2025-07-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 24, 2025

 

OSR HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-41390   84-5052822
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

10900 NE 4th Street, Suite 2300, Bellevue, WA   98004
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code (425) 635-7700

 

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Common stock, par value $0.0001 per share   OSRH   The Nasdaq Stock Market LLC
Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share   OSRHW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 Item 8.01 Other Events.

 

On July 24, 2025, OSR Holdings, Inc. (the “Company”), together with OSR Holdings Co., Ltd. (“OSRK”), entered into a non-binding term sheet with Woori IO Co., Ltd. (“WORIO”), outlining the principal terms of a proposed share exchange transaction pursuant to which WORIO would become a wholly owned subsidiary of OSRK.

 

Pursuant to the term sheet, WORIO shareholders would receive newly issued shares of OSRK, which may be convertible into Company common stock within three years, subject to certain conditions. The parties also agreed to a six-month exclusivity period and to conduct mutual due diligence. The transaction is subject to the negotiation and execution of definitive agreements.

 

A copy of the term sheet is filed as Exhibit 10.1 and incorporated herein by reference. A formal press release was issued by the Company on July 24, 2025.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

EXHIBIT INDEX

 

Exhibit No.   Description
10.1   Term Sheet, dated as of July 24, 2025, between OSR Holdings Co., Ltd., OSR Holdings, Inc,. and Woori IO Co., Ltd.
99.1   Press Release, dated July, 24, 2025, announcing entry into term sheet with Woori IO Co., Ltd.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 25, 2025

 

  OSR HOLDINGS, INC.
       
  By:   /s/ Kuk Hyoun Hwang
    Name:  Kuk Hyoun Hwang
    Title: Chief Executive Officer

 

 

2

 

FAQ

How much capital can Callan JMB (CJMB) raise under the new ELOC?

The company may sell up to $25 million of common stock to the investor over an 18-month term.

At what price will CJMB shares be sold to the investor?

Regular and exemption purchases are priced at 95 % of the lowest daily VWAP in the measurement period (80 % if delisted).

What dilution protections exist for existing CJMB shareholders?

The investor’s stake is capped at 4.99 %, but discounted pricing and bonus shares still dilute current holders.

What happens if CJMB misses the registration filing deadline?

The company must issue an additional 25,000 shares to the investor if it fails to file or make effective the registration statement on time.

Is CJMB obligated to use the ELOC?

No. Management decides whether and when to issue purchase notices; the facility is purely discretionary.
OSR Holdings, Inc.

NASDAQ:OSRH

OSRH Rankings

OSRH Latest News

OSRH Latest SEC Filings

OSRH Stock Data

20.20M
7.25M
Surgical & Medical Instruments & Apparatus
BELLEVUE